ERO COPPER CORP (ERO) Fundamental Analysis & Valuation

NYSE:ERO • CA2960061091

Current stock price

25.21 USD
-0.64 (-2.48%)
At close:
25.56 USD
+0.35 (+1.39%)
After Hours:

This ERO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ERO Profitability Analysis

1.1 Basic Checks

  • In the past year ERO was profitable.
  • In the past year ERO had a positive cash flow from operations.
  • ERO had positive earnings in 4 of the past 5 years.
  • ERO had a positive operating cash flow in each of the past 5 years.
ERO Yearly Net Income VS EBIT VS OCF VS FCFERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.71%, ERO belongs to the top of the industry, outperforming 90.80% of the companies in the same industry.
  • With an excellent Return On Equity value of 28.19%, ERO belongs to the best of the industry, outperforming 93.86% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 13.17%, ERO belongs to the top of the industry, outperforming 84.05% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ERO is significantly below the industry average of 58.77%.
  • The 3 year average ROIC (8.91%) for ERO is below the current ROIC(13.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.71%
ROE 28.19%
ROIC 13.17%
ROA(3y)5.05%
ROA(5y)10.57%
ROE(3y)9.36%
ROE(5y)19.62%
ROIC(3y)8.91%
ROIC(5y)15.07%
ERO Yearly ROA, ROE, ROICERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • ERO's Profit Margin of 33.56% is amongst the best of the industry. ERO outperforms 90.80% of its industry peers.
  • In the last couple of years the Profit Margin of ERO has grown nicely.
  • Looking at the Operating Margin, with a value of 34.57%, ERO is in the better half of the industry, outperforming 79.14% of the companies in the same industry.
  • ERO's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 43.99%, ERO is in the better half of the industry, outperforming 74.23% of the companies in the same industry.
  • ERO's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 34.57%
PM (TTM) 33.56%
GM 43.99%
OM growth 3Y4.33%
OM growth 5Y-5.81%
PM growth 3Y12.01%
PM growth 5Y16.08%
GM growth 3Y0.07%
GM growth 5Y-5.39%
ERO Yearly Profit, Operating, Gross MarginsERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ERO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ERO is creating some value.
  • The number of shares outstanding for ERO has been increased compared to 1 year ago.
  • ERO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ERO has an improved debt to assets ratio.
ERO Yearly Shares OutstandingERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ERO Yearly Total Debt VS Total AssetsERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 3.02 indicates that ERO is not in any danger for bankruptcy at the moment.
  • ERO has a Altman-Z score of 3.02. This is comparable to the rest of the industry: ERO outperforms 44.17% of its industry peers.
  • ERO has a debt to FCF ratio of 5.61. This is a neutral value as ERO would need 5.61 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.61, ERO is in the better half of the industry, outperforming 68.71% of the companies in the same industry.
  • ERO has a Debt/Equity ratio of 0.60. This is a neutral value indicating ERO is somewhat dependend on debt financing.
  • ERO's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. ERO is outperformed by 76.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.61
Altman-Z 3.02
ROIC/WACC1.07
WACC12.26%
ERO Yearly LT Debt VS Equity VS FCFERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ERO should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.06, ERO is doing worse than 81.60% of the companies in the same industry.
  • A Quick Ratio of 0.63 indicates that ERO may have some problems paying its short term obligations.
  • ERO's Quick ratio of 0.63 is on the low side compared to the rest of the industry. ERO is outperformed by 83.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.63
ERO Yearly Current Assets VS Current LiabilitesERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ERO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 171.79% over the past year.
  • Measured over the past years, ERO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.14% on average per year.
  • ERO shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.11%.
  • Measured over the past years, ERO shows a quite strong growth in Revenue. The Revenue has been growing by 19.38% on average per year.
EPS 1Y (TTM)171.79%
EPS 3Y32.57%
EPS 5Y11.14%
EPS Q2Q%511.76%
Revenue 1Y (TTM)67.11%
Revenue growth 3Y22.61%
Revenue growth 5Y19.38%
Sales Q2Q%161.35%

3.2 Future

  • Based on estimates for the next years, ERO will show a decrease in Earnings Per Share. The EPS will decrease by -1.37% on average per year.
  • Based on estimates for the next years, ERO will show a small growth in Revenue. The Revenue will grow by 4.45% on average per year.
EPS Next Y84.39%
EPS Next 2Y42.92%
EPS Next 3Y24.15%
EPS Next 5Y-1.37%
Revenue Next Year53.11%
Revenue Next 2Y25.23%
Revenue Next 3Y14.8%
Revenue Next 5Y4.45%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ERO Yearly Revenue VS EstimatesERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ERO Yearly EPS VS EstimatesERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

9

4. ERO Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.89 indicates a reasonable valuation of ERO.
  • Based on the Price/Earnings ratio, ERO is valued cheaply inside the industry as 93.86% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.51. ERO is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 6.45 indicates a rather cheap valuation of ERO.
  • ERO's Price/Forward Earnings ratio is rather cheap when compared to the industry. ERO is cheaper than 92.64% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.41. ERO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.89
Fwd PE 6.45
ERO Price Earnings VS Forward Price EarningsERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ERO is valued cheaply inside the industry as 82.21% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ERO indicates a rather cheap valuation: ERO is cheaper than 84.05% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.33
EV/EBITDA 8.15
ERO Per share dataERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • ERO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ERO may justify a higher PE ratio.
  • ERO's earnings are expected to grow with 24.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)1.07
EPS Next 2Y42.92%
EPS Next 3Y24.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ERO Dividend Analysis

5.1 Amount

  • No dividends for ERO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ERO Fundamentals: All Metrics, Ratios and Statistics

ERO COPPER CORP

NYSE:ERO (5/1/2026, 8:24:02 PM)

After market: 25.56 +0.35 (+1.39%)

25.21

-0.64 (-2.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry Strength92.19
Industry Growth17.16
Earnings (Last)03-05
Earnings (Next)05-04
Inst Owners72.42%
Inst Owner Change-0.3%
Ins Owners5.86%
Ins Owner ChangeN/A
Market Cap2.63B
Revenue(TTM)785.84M
Net Income(TTM)263.72M
Analysts74
Price Target36.45 (44.59%)
Short Float %3.66%
Short Ratio2.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-22.39%
Min EPS beat(2)-43.87%
Max EPS beat(2)-0.91%
EPS beat(4)2
Avg EPS beat(4)1.14%
Min EPS beat(4)-43.87%
Max EPS beat(4)38.12%
EPS beat(8)4
Avg EPS beat(8)0.8%
EPS beat(12)5
Avg EPS beat(12)-1.14%
EPS beat(16)5
Avg EPS beat(16)-10.65%
Revenue beat(2)1
Avg Revenue beat(2)-4.91%
Min Revenue beat(2)-19.98%
Max Revenue beat(2)10.15%
Revenue beat(4)1
Avg Revenue beat(4)-8.99%
Min Revenue beat(4)-19.98%
Max Revenue beat(4)10.15%
Revenue beat(8)2
Avg Revenue beat(8)-9.05%
Revenue beat(12)3
Avg Revenue beat(12)-7.71%
Revenue beat(16)4
Avg Revenue beat(16)-8.04%
PT rev (1m)4.98%
PT rev (3m)27.92%
EPS NQ rev (1m)-21.02%
EPS NQ rev (3m)-30.69%
EPS NY rev (1m)-4.06%
EPS NY rev (3m)1.16%
Revenue NQ rev (1m)-3.56%
Revenue NQ rev (3m)10.26%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)4.28%
Valuation
Industry RankSector Rank
PE 11.89
Fwd PE 6.45
P/S 3.35
P/FCF 23.33
P/OCF 6.65
P/B 2.81
P/tB 2.81
EV/EBITDA 8.15
EPS(TTM)2.12
EY8.41%
EPS(NY)3.91
Fwd EY15.51%
FCF(TTM)1.08
FCFY4.29%
OCF(TTM)3.79
OCFY15.03%
SpS7.54
BVpS8.97
TBVpS8.97
PEG (NY)0.14
PEG (5Y)1.07
Graham Number20.6866 (-17.94%)
Profitability
Industry RankSector Rank
ROA 13.71%
ROE 28.19%
ROCE 16.33%
ROIC 13.17%
ROICexc 14.06%
ROICexgc 14.06%
OM 34.57%
PM (TTM) 33.56%
GM 43.99%
FCFM 14.34%
ROA(3y)5.05%
ROA(5y)10.57%
ROE(3y)9.36%
ROE(5y)19.62%
ROIC(3y)8.91%
ROIC(5y)15.07%
ROICexc(3y)9.49%
ROICexc(5y)18.57%
ROICexgc(3y)9.49%
ROICexgc(5y)18.57%
ROCE(3y)11.05%
ROCE(5y)18.68%
ROICexgc growth 3Y-0.12%
ROICexgc growth 5Y-16.92%
ROICexc growth 3Y-0.12%
ROICexc growth 5Y-16.92%
OM growth 3Y4.33%
OM growth 5Y-5.81%
PM growth 3Y12.01%
PM growth 5Y16.08%
GM growth 3Y0.07%
GM growth 5Y-5.39%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 5.61
Debt/EBITDA 1.45
Cap/Depr 244.1%
Cap/Sales 35.94%
Interest Coverage 6.36
Cash Conversion 102%
Profit Quality 42.73%
Current Ratio 1.06
Quick Ratio 0.63
Altman-Z 3.02
F-Score8
WACC12.26%
ROIC/WACC1.07
Cap/Depr(3y)395.05%
Cap/Depr(5y)414.26%
Cap/Sales(3y)71.83%
Cap/Sales(5y)64.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)171.79%
EPS 3Y32.57%
EPS 5Y11.14%
EPS Q2Q%511.76%
EPS Next Y84.39%
EPS Next 2Y42.92%
EPS Next 3Y24.15%
EPS Next 5Y-1.37%
Revenue 1Y (TTM)67.11%
Revenue growth 3Y22.61%
Revenue growth 5Y19.38%
Sales Q2Q%161.35%
Revenue Next Year53.11%
Revenue Next 2Y25.23%
Revenue Next 3Y14.8%
Revenue Next 5Y4.45%
EBIT growth 1Y124.57%
EBIT growth 3Y27.92%
EBIT growth 5Y12.45%
EBIT Next Year151.41%
EBIT Next 3Y35.63%
EBIT Next 5Y20.01%
FCF growth 1Y158.65%
FCF growth 3YN/A
FCF growth 5Y20.15%
OCF growth 1Y171.72%
OCF growth 3Y40.2%
OCF growth 5Y19.4%

ERO COPPER CORP / ERO Fundamental Analysis FAQ

What is the fundamental rating for ERO stock?

ChartMill assigns a fundamental rating of 6 / 10 to ERO.


What is the valuation status of ERO COPPER CORP (ERO) stock?

ChartMill assigns a valuation rating of 9 / 10 to ERO COPPER CORP (ERO). This can be considered as Undervalued.


Can you provide the profitability details for ERO COPPER CORP?

ERO COPPER CORP (ERO) has a profitability rating of 7 / 10.


What is the financial health of ERO COPPER CORP (ERO) stock?

The financial health rating of ERO COPPER CORP (ERO) is 4 / 10.